Hepatocellular Carcinoma News and Research

RSS
Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

Prognosis still poor for EVB in cirrhosis

Prognosis still poor for EVB in cirrhosis

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Enrollment complete in Boehringer Ingelheim’s nintedanib phase III studies for IPF

Enrollment complete in Boehringer Ingelheim’s nintedanib phase III studies for IPF

Jennerex Phase 2 JX-594 clinical data for hepatocellular carcinoma presented at ILCA meeting

Jennerex Phase 2 JX-594 clinical data for hepatocellular carcinoma presented at ILCA meeting

Exercise, good nutrition play a crucial role in maintaining health and fighting disease

Exercise, good nutrition play a crucial role in maintaining health and fighting disease

GSK, University of Cambridge aim to discover and develop new medicines for liver disease

GSK, University of Cambridge aim to discover and develop new medicines for liver disease

Children and young patients with chronic HBV infection do have a protective immune response

Children and young patients with chronic HBV infection do have a protective immune response

Telaprevir offers advantages in patients with chronic hepatitis C infection of genotype 1

Telaprevir offers advantages in patients with chronic hepatitis C infection of genotype 1

Assumptions about liver transplant wait-list mortality challenged

Assumptions about liver transplant wait-list mortality challenged

NYGC purchases four Life Technologies' Ion Proton Sequencers

NYGC purchases four Life Technologies' Ion Proton Sequencers

Gluconeogenesis severely compromised in HCC by IL6-Stat3-mediated activation of miR-23a

Gluconeogenesis severely compromised in HCC by IL6-Stat3-mediated activation of miR-23a

Jennerex initiates JX-594 Phase 2 trial in advanced hepatocellular carcinoma

Jennerex initiates JX-594 Phase 2 trial in advanced hepatocellular carcinoma

Bayer, Onyx and Astellas announce results from Tarceva plus Nexavar Phase 3 trial on HCC

Bayer, Onyx and Astellas announce results from Tarceva plus Nexavar Phase 3 trial on HCC

Bristol-Myers Squibb reports results from brivanib plus sorafenib phase III trial on HCC

Bristol-Myers Squibb reports results from brivanib plus sorafenib phase III trial on HCC

HCV infections can lead to increased mortality from liver disease or variety of other causes

HCV infections can lead to increased mortality from liver disease or variety of other causes

Estrogen may mediate low incidence of HCC in women

Estrogen may mediate low incidence of HCC in women

Activating NOTCH and AKT gene may trigger cholangiocarcinoma

Activating NOTCH and AKT gene may trigger cholangiocarcinoma

Research reveals how metformin reduces HCC risk

Research reveals how metformin reduces HCC risk

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.